PF-07976016
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Pfizer · Phase 2 · Completed · Enrollment 263
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| PF-07976016 Dose 1 | n/r | n/r | n/r | n/r |
| PF-07976016 Dose 2 | n/r | n/r | n/r | n/r |
| PF-07976016 Dose 3 | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- PF-07976016 Dose 1: endpoint not reported
- PF-07976016 Dose 2: endpoint not reported
- PF-07976016 Dose 3: endpoint not reported
- Placebo: endpoint not reported